Non Serious Adverse Drug Reactions Report

Start Date:2016-03-22 End Date:2016-03-23
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0136Subject Initials :Q-LDOB :03/28/1984Sex:FemaleRace:AsianHeight:154cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/08/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstruction incompleteUk-Unk-2014Not on treatment/medication
 



22-MAR-16
NA/EMR700623-541/C02-0136
Page 1 of 69
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-22 End Date:2016-03-23
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0137Subject Initials :YLFDOB :11/01/1989Sex:FemaleRace:AsianHeight:153cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/09/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstructionUk-Unk-2014Not on treatment/medication
 



22-MAR-16
NA/EMR700623-541/C02-0137
Page 2 of 69
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-22 End Date:2016-03-23
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0138Subject Initials :TTJDOB :06/20/1990Sex:FemaleRace:AsianHeight:150cmWeight:41.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/06/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy laparoscopic surgery: the right fallopian tube embryo pelvic sticking pointsUk-Jan-2014Not on treatment/medication
Hysteroscopy: endometrial polyps.Uk-Feb-2015Not on treatment/medication
 



22-MAR-16
NA/EMR700623-541/C02-0138
Page 3 of 69
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-22 End Date:2016-03-23
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C04
Subject No :C04-0087Subject Initials :HZDDOB :08/04/1983Sex:FemaleRace:AsianHeight:161cmWeight:60kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment06/26/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS07/07/201507/21/2015RelatedMild
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Dose reducedNoneResolved
Event description:none
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
spontaneous abortion01/05/2010Not on treatment/medication
spontaneous abortion05/18/2012Not on treatment/medication
 



22-MAR-16
NA/EMR700623-541/C04-0087
Page 4 of 69
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-22 End Date:2016-03-23
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C04
Subject No :C04-0171Subject Initials :SHLDOB :08/17/1987Sex:FemaleRace:AsianHeight:154cmWeight:40kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/30/201510/09/2015RelatedMild
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Dose reducedNoneResolved
Event description:none
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing
 



22-MAR-16
NA/EMR700623-541/C04-0171
Page 5 of 69
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-22 End Date:2016-03-23
Study :EMR200136_583Investigator :NACountry of Investigator :RomaniaSiteNo:007
Subject No :007-0014Subject Initials :DOB :09/02/1988Sex:MaleRace:CaucasianHeight:181(cm)Weight:69(kg)
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Visit 2 (Month 3)06/29/20159
Visit 3 (Month 6)06/29/20159
Visit 1/ Baseline (Day 1)06/29/20159
Visit 4 (Month 9)06/29/20159
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
flu-like symptoms12/22/2015SuspectedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Dose not changedNoneOngoing
Event description:
Subject received concomitant medications:Yes
Name of medicationStart DateOngoingEnd DateDoseUnitFrequency
Driptane05/18/2015Yes5mgQD
Lioresal05/18/2015Yes15mgTID
Acetaminophen 12/22/2015Yes500mgPRN
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



22-MAR-16
NA/EMR200136_583/007-0014
Page 6 of 69